Literature DB >> 9891045

Complementation of defective colony-stimulating factor 1 receptor signaling and mitogenesis by Raf and v-Src.

N Aziz1, H Cherwinski, M McMahon.   

Abstract

Ras-activated signal transduction pathways are implicated in the control of cell proliferation, differentiation, apoptosis, and tumorigenesis, but the molecular mechanisms mediating these diverse functions have yet to be fully elucidated. Conditionally active forms of Raf, v-Src, and MEK1 were used to identify changes in gene expression that participate in oncogenic transformation, as well as in normal growth control. Activation of Raf, v-Src, and MEK1 led to induced expression of c-Myc and cyclin D1. Induction of c-Myc mRNA by Raf was an immediate-early response, whereas the induction of cyclin D1 mRNA was delayed and inhibited by cycloheximide. Raf activation also resulted in the induction of an established c-Myc target gene, ornithine decarboxylase (ODC). ODC induction by Raf was mediated, in part, by tandem E-boxes contained in the first intron of the gene. Activation of the human colony-stimulating factor 1 (CSF-1) receptor in NIH 3T3 cells leads to activation of the mitogen-activated protein (MAP) kinase pathway and induced expression of c-Fos, c-Myc, and cyclin D1, leading to a potent mitogenic response. By contrast, a mutated form of this receptor fails to activate the MAP kinases or induce c-Myc and cyclin D1 expression and fails to elicit a mitogenic response. The biological significance of c-Myc and cyclin D1 induction by Raf and v-Src was confirmed by the demonstration that both of these protein kinases complemented the signaling and mitogenic defects of cells expressing this mutated form of the human CSF-1 receptor. Furthermore, the induction of c-Myc and cyclin D1 by oncogenes and growth factors was inhibited by PD098059, a specific MAP kinase kinase (MEK) inhibitor. These data suggest that the Raf/MEK/MAP kinase pathway plays an important role in the regulation of c-Myc and cyclin D1 expression in NIH 3T3 cells. The ability of oncogenes such as Raf and v-Src to regulate the expression of these proteins reveals new lines of communication between cytosolic signal transducers and the cell cycle machinery.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9891045      PMCID: PMC116040          DOI: 10.1128/MCB.19.2.1101

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  138 in total

Review 1.  c-myc hypermutation in Burkitt's lymphoma.

Authors:  J M Johnston; W L Carroll
Journal:  Leuk Lymphoma       Date:  1992-12

2.  Multiple promoter elements govern expression of the human ornithine decarboxylase gene in colon carcinoma cells.

Authors:  J A Moshier; D L Osborne; M Skunca; J Dosescu; J D Gilbert; M C Fitzgerald; G Polidori; R L Wagner; S J Friezner Degen; G D Luk
Journal:  Nucleic Acids Res       Date:  1992-05-25       Impact factor: 16.971

3.  c-myc antisense oligonucleotides inhibit the colony-forming capacity of Colo 320 colonic carcinoma cells.

Authors:  J F Collins; P Herman; C Schuch; G C Bagby
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

4.  Multiple DNA elements responsible for transcriptional regulation of the ornithine decarboxylase gene by protein kinase A.

Authors:  M S Abrahamsen; R S Li; W Dietrich-Goetz; D R Morris
Journal:  J Biol Chem       Date:  1992-09-15       Impact factor: 5.157

5.  Myc and Max proteins possess distinct transcriptional activities.

Authors:  L Kretzner; E M Blackwood; R N Eisenman
Journal:  Nature       Date:  1992-10-01       Impact factor: 49.962

6.  Both p21ras and pp60v-src are required, but neither alone is sufficient, to activate the Raf-1 kinase.

Authors:  N G Williams; T M Roberts; P Li
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

7.  Raf-1 activates MAP kinase-kinase.

Authors:  J M Kyriakis; H App; X F Zhang; P Banerjee; D L Brautigan; U R Rapp; J Avruch
Journal:  Nature       Date:  1992-07-30       Impact factor: 49.962

8.  Activation of mitogen-activated protein kinase kinase by v-Raf in NIH 3T3 cells and in vitro.

Authors:  P Dent; W Haser; T A Haystead; L A Vincent; T M Roberts; T W Sturgill
Journal:  Science       Date:  1992-09-04       Impact factor: 47.728

9.  Raf functions downstream of Ras1 in the Sevenless signal transduction pathway.

Authors:  B Dickson; F Sprenger; D Morrison; E Hafen
Journal:  Nature       Date:  1992-12-10       Impact factor: 49.962

10.  Mitogenic signaling by colony-stimulating factor 1 and ras is suppressed by the ets-2 DNA-binding domain and restored by myc overexpression.

Authors:  S J Langer; D M Bortner; M F Roussel; C J Sherr; M C Ostrowski
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

View more
  16 in total

1.  Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways.

Authors:  C V Ramana; N Grammatikakis; M Chernov; H Nguyen; K C Goh; B R Williams; G R Stark
Journal:  EMBO J       Date:  2000-01-17       Impact factor: 11.598

2.  Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion.

Authors:  Dimitrios Iliopoulos; Heather A Hirsch; Guannan Wang; Kevin Struhl
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

3.  Inhibition of miR-193a expression by Max and RXRα activates K-Ras and PLAU to mediate distinct aspects of cellular transformation.

Authors:  Dimitrios Iliopoulos; Asaf Rotem; Kevin Struhl
Journal:  Cancer Res       Date:  2011-06-13       Impact factor: 12.701

4.  Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis.

Authors:  T Bowman; M A Broome; D Sinibaldi; W Wharton; W J Pledger; J M Sedivy; R Irby; T Yeatman; S A Courtneidge; R Jove
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-12       Impact factor: 11.205

5.  The transcription factor T-box 3 regulates colony-stimulating factor 1-dependent Jun dimerization protein 2 expression and plays an important role in osteoclastogenesis.

Authors:  Chen Yao; Gang-Qing Yao; Ben-Hua Sun; Changqing Zhang; Steven M Tommasini; Karl Insogna
Journal:  J Biol Chem       Date:  2014-01-06       Impact factor: 5.157

6.  Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells.

Authors:  Dimitrios Iliopoulos; Marianne Lindahl-Allen; Christos Polytarchou; Heather A Hirsch; Philip N Tsichlis; Kevin Struhl
Journal:  Mol Cell       Date:  2010-09-10       Impact factor: 17.970

7.  Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway.

Authors:  D Woods; H Cherwinski; E Venetsanakos; A Bhat; S Gysin; M Humbert; P F Bray; V L Saylor; M McMahon
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

8.  Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT.

Authors:  Amer M Mirza; Stephan Gysin; Nisar Malek; Kei-ichi Nakayama; James M Roberts; Martin McMahon
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

9.  An integrated transcriptional regulatory circuit that reinforces the breast cancer stem cell state.

Authors:  Christos Polytarchou; Dimitrios Iliopoulos; Kevin Struhl
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

10.  B-Raf activation cooperates with PTEN loss to drive c-Myc expression in advanced prostate cancer.

Authors:  Jingqiang Wang; Takashi Kobayashi; Nicolas Floc'h; Carolyn Waugh Kinkade; Alvaro Aytes; David Dankort; Celine Lefebvre; Antonina Mitrofanova; Robert D Cardiff; Martin McMahon; Andrea Califano; Michael M Shen; Cory Abate-Shen
Journal:  Cancer Res       Date:  2012-07-25       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.